Discontinued — last reported Q3 '24
Cardiovascular — Operating Income Allocated to Reportable Segments
Boston Scientific Cardiovascular — Operating Income Allocated to Reportable Segments increased by 10.6% to $842.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 47.7%, from $570.00M to $842.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates improved profitability and operational scale within the cardiovascular division, while a decrease may signal rising costs, pricing pressure, or declining demand for cardiovascular medical devices.
Detailed definition
This metric represents the absolute dollar amount of operating profit generated by the cardiovascular business unit afte...
Peer comparison
Comparable to segment-level operating income reported by other diversified medical device manufacturers, though specific allocation methodologies for shared corporate costs may vary.
bsx_segment_cardiovascular_operating_income_allocated_to_reportable_segmentsHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $418.00M | $361.00M | $477.00M | $543.00M | $542.00M | $541.00M | $566.00M | $570.00M | $653.00M | $761.00M | $842.00M |
| QoQ Change | — | -13.6% | +32.1% | +13.8% | -0.2% | -0.2% | +4.6% | +0.7% | +14.6% | +16.5% | +10.6% |
| YoY Change | — | — | — | +29.9% | +50.1% | +13.4% | +4.2% | +5.2% | +20.7% | +34.5% | +47.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — operating income allocated to reportable segments?
- Boston Scientific (BSX) reported cardiovascular — operating income allocated to reportable segments of $842.00M in Q3 2024.
- How has Boston Scientific's cardiovascular — operating income allocated to reportable segments changed year-over-year?
- Boston Scientific's cardiovascular — operating income allocated to reportable segments increased by 47.7% year-over-year, from $570.00M to $842.00M.
- What does cardiovascular — operating income allocated to reportable segments mean?
- The total operating profit earned specifically by the cardiovascular business segment.